Published in Kidney Int on March 01, 1985
Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol (1998) 1.44
Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2009) 1.35
Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest (1985) 1.31
Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2. J Leukoc Biol (2009) 1.20
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat. Clin Exp Immunol (1990) 1.16
Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol (1986) 0.98
The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol (1986) 0.98
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
Anti-idiotype and immunosuppressant treatment of murine lupus. Clin Exp Immunol (1991) 0.95
Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits. J Clin Invest (1988) 0.87
New insights into mechanisms of immune glomerular injury. West J Med (1994) 0.87
Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat. Clin Exp Immunol (1991) 0.86
Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness. Clin Exp Immunol (2000) 0.86
IL-1-like production in adriamycin-induced nephrotic syndrome in the rat. Clin Exp Immunol (1992) 0.84
Cell-mediated pathology during murine malaria-associated nephritis. Clin Exp Immunol (1993) 0.82
Cyclosporin A and anti-glomerular basement membrane antibody glomerulonephritis in rats. Br J Exp Pathol (1988) 0.81
Cyclosporin A induces long-term unresponsiveness in mercuric chloride-induced autoimmune glomerulonephritis. Clin Exp Immunol (1988) 0.79
Tissue factor in crescentic glomerulonephritis. Am J Pathol (1997) 0.75
Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1. PLoS One (2015) 0.75
Activated T-lymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells. Clin Exp Immunol (1992) 0.75
The effect of cyclosporin A on rabbit nephrotoxic glomerulonephritis. Int J Exp Pathol (1993) 0.75
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol (1999) 2.11
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int (1997) 1.66
Familial cystic nephroma and pleuropulmonary blastoma. Cancer (1993) 1.59
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int (1999) 1.55
Rhodococcus equi: an emerging opportunistic pathogen? Aust N Z J Med (1989) 1.55
Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest (1991) 1.49
Role of CFTR mutations in adult bronchiectasis. Thorax (2004) 1.46
Glomerular antigens in Heymann's nephritis: reactivity of eluted and circulating antibody. J Immunol (1982) 1.45
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med (2000) 1.44
Organic manic syndrome associated with advanced uraemia due to polycystic kidney disease. Br J Psychiatry (1991) 1.40
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis) J Am Soc Nephrol (1996) 1.38
An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis. J Immunol (1986) 1.38
Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int (1997) 1.35
Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet (1988) 1.32
Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest (1985) 1.31
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol (1999) 1.27
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol (1997) 1.25
Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood (1999) 1.25
Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol (1997) 1.23
Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int (1994) 1.23
Letter: Amyloid fibrils in urinary sediment. N Engl J Med (1976) 1.19
P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol (2001) 1.19
A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun (2010) 1.16
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys. Lab Invest (1982) 1.15
Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int (2000) 1.15
Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis (1989) 1.15
Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest (1988) 1.14
Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade. Br Med J (1976) 1.08
Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol (1995) 1.08
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
Parathyroid surgery in chronic renal failure. N Z Med J (1985) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis. Lab Invest (1984) 1.06
The participation of macrophages and monocytes in experimental immune complex glomerulonephritis. Clin Immunol Immunopathol (1980) 1.06
Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation (1997) 1.05
Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int (1991) 1.04
Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol (1996) 1.04
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int (1998) 1.01
IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol (1999) 1.01
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol (1997) 1.00
Cell characteristics of cultured glomeruli from different animal species. Nephron (1978) 0.99
Spironolactone-associated aggravation of renal functional impairment. N Z Med J (1976) 0.98
Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int (1997) 0.98
The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol (1986) 0.98
Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int (1986) 0.97
The immunochemical characterisation of circulating immune complex constituents in Candida albicans osteomyelitis by isoelectric focusing, immunoblot, and immunoprint. Aust N Z J Med (1987) 0.97
Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron (1985) 0.97
Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol (2000) 0.96
Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int (1986) 0.96
The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol (1978) 0.96
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol (1986) 0.93
Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis (1995) 0.92
Tissue culture of isolated glomeruli from patients with glomerulonephritis. Kidney Int (1980) 0.92
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol (2002) 0.92
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol (1999) 0.91
Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis (1986) 0.91
IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol (2000) 0.90
Alveolar macrophage procoagulant activity is increased in acute hyperoxic lung injury. Am J Pathol (1988) 0.90
Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response? Histol Histopathol (2000) 0.90
Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int (1989) 0.89